Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

MedMen Congratulates Board Member Stacey Hallerman on New Role at Lowell Herb Co

Stacey Hallerman Resigns from MedMen Board of Directors to Become Chief Administrative Officer and General Counsel at Lowell

MedMen Congratulates Board Member Stacey Hallerman on New Role at Lowell Herb CoLOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) (“MedMen” or the “Company”), a leading cannabis retailer with operations across the U.S., today announced that Stacey Hallerman has resigned from the Company’s Board of Directors, effective immediately. Ms. Hallerman has left her position on MedMen’s Board to assume the role of Chief Administrative Officer and General Counsel at Lowell Herb Co. (“Lowell”).

“MedMen has been a strong supporter of Lowell from the start, and we look forward to finding additional ways to work with Stacey in her new role at Lowell. We wish her the best of luck in her future endeavors.”

Tweet this

“On behalf of my fellow directors, MedMen’s management team and our shareholders, I’d like to thank Stacey for her valuable contributions to our board,” said Adam Bierman, MedMen co-founder and chief executive officer. “MedMen has been a strong supporter of Lowell from the start, and we look forward to finding additional ways to work with Stacey in her new role at Lowell. We wish her the best of luck in her future endeavors.”

Lowell was one of MedMen’s first strategic investments into a cannabis brand. Back in July 2018, the Company announced an investment in the Lowell Herb Co. At the time, a main driver for the investment was that Lowell and MedMen shared a similar vision of cannabis as a consumer product, and that shared vision endures. MedMen currently sells Lowell’s products across its California network.

About MedMen:

Founded in 2010, MedMen is North America’s premium cannabis retailer. Founders Adam Bierman and Andrew Modlin have defined the next generation discovery platform for cannabis and all its benefits. A robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLyte and MedMen Red, coupled with a team of cannabis-educated associates cement the Company’s commitment to providing an unparalleled experience. MedMen’s industry-leading technology enables a fully compliant, owned-and-operated delivery service and MedMen Buds, a nationwide loyalty program.

MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more at www.MedMen.com.

Source: MedMen Enterprises

Should you invest in MedMen Enterprises? See our technical and fundamental analysis reporting to determine if MedMen is a strong cannabis investment.

Contacts

OFFICER CONTACT:
Adam Bierman, 855-292-8399
Chief Executive Officer
info@medmen.com

MEDIA CONTACT:
Christian Langbein, 424-320-2367
VP of Communications
communications@medmen.com

INVESTOR RELATIONS CONTACT:
Stéphanie Van Hassel, 323-705-3025
VP of Investor Relations
investors@medmen.com

MedMen Congratulates Board Member Stacey Hallerman on New Role at Lowell Herb Co

About Cannin: Your Marijuana Stock Experts

Cannin is your #1 trusted resource for marijuana and hemp stock investment opportunities. Our global team of experts evaluates all emerging marijuana and hemp stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana and hemp stock investments for 2020. 

Use Cannin as your resource for:

Is it too late to invest in marijuana or hemp stocks? No! This is the perfect time to invest.

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana and hemp stocks is now. Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in emerging penny hemp stock companies? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana and hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

We’re so confident you’ll love our signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best marijuana stocks – we’ll show you how at cannin.com

Can we start writing exclusively about Hemp-Only companies? These include the following: Charlotte’s Web, GW Pharma, CV Sciences, Canopy Growth, Elixinol, Organigram, GrowLife, Emerald Health, Neptune, Global Hemp Group. Also, please see the attached report with additional hemp only companies with analysis. It’s from last year so the data is not current but worth a look.

Hemp Stocks, Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading